Section Arrow
CVRX.NASDAQ
- CVRx
Quotes are at least 15-min delayed:2026/11/20 17:53 EST
After Hours
Last
 0.5109
+0.0099 (+1.98%)
Bid
0.497
Ask
0.55
High 0.52 
Low 0.501 
Volume 425 
Regular Hours (Closed)
Last
 0.501
-0.0319 (-5.99%)
Day High 
0.569 
Prev. Close
0.5329 
1-M High
1.6 
Volume 
520.26K 
Bid
0.497
Ask
0.55
Day Low
0.4972 
Open
0.5252 
1-M Low
0.5297 
Market Cap 
15.18M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.66 
20-SMA 1.05 
50-SMA 1.66 
52-W High 10.28 
52-W Low 0.5297 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.00/-1.94
Enterprise Value
65.33M
Balance Sheet
Book Value Per Share
0.49
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
56.65M
Operating Revenue Per Share
1.23
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp41.98-1.01-2.35%18.14PE
After Hours 42.3233 +0.3433 +0.82%
PACBPacific Biosciences of California1.63-0.13-7.39%-- 
After Hours 1.65 +0.02 +1.23%
MDTMedtronic plc99.94-0.67-0.67%24.78PE
After Hours 99.52 -0.42 -0.42%
QSIQuantum-Si0.909-0.161-15.05%-- 
After Hours 0.93 +0.021 +2.31%
ABTAbbott Laboratories103-0.87-0.84%38.76PE
After Hours 103.53 +0.53 +0.51%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.